Back to Search
Start Over
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
- Source :
-
Leukemia [Leukemia] 2016 Apr; Vol. 30 (4), pp. 984-7. Date of Electronic Publication: 2015 Aug 05. - Publication Year :
- 2016
- Subjects :
- Aged
Aged, 80 and over
Europe
Female
Follow-Up Studies
Humans
Lymphoma, Mantle-Cell immunology
Lymphoma, Mantle-Cell mortality
Lymphoma, Mantle-Cell pathology
Male
Middle Aged
Neoplasm Recurrence, Local immunology
Neoplasm Recurrence, Local mortality
Neoplasm Recurrence, Local pathology
Neoplasm Staging
Prognosis
Prospective Studies
Survival Rate
Antibodies, Monoclonal therapeutic use
Drug Resistance, Neoplasm
Lymphoma, Mantle-Cell therapy
Neoplasm Recurrence, Local therapy
Radioimmunotherapy
Yttrium Radioisotopes therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 30
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 26242461
- Full Text :
- https://doi.org/10.1038/leu.2015.215